Xiaolan Lin

432 total citations
27 papers, 277 citations indexed

About

Xiaolan Lin is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Xiaolan Lin has authored 27 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Xiaolan Lin's work include Phytochemicals and Antioxidant Activities (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Xiaolan Lin is often cited by papers focused on Phytochemicals and Antioxidant Activities (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Xiaolan Lin collaborates with scholars based in China, Canada and Uganda. Xiaolan Lin's co-authors include Wei Zhuang, Yuewen Gong, Yumin Luo, Fei Chen, Lifeng Yue, Shengyan Xi, Ge Sun, Ying Yang, Li Wu and Yuqiao Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Science Advances and Frontiers in Immunology.

In The Last Decade

Xiaolan Lin

26 papers receiving 276 citations

Peers

Xiaolan Lin
Ashraf Ul Kabir United States
Zhengzhong Wang China
Lifeng Yue China
Yajie Cai China
Hyeon‐Hui Ki South Korea
Mengting Yu China
Tianli Pei China
Chuangpeng Shen China
Ashraf Ul Kabir United States
Xiaolan Lin
Citations per year, relative to Xiaolan Lin Xiaolan Lin (= 1×) peers Ashraf Ul Kabir

Countries citing papers authored by Xiaolan Lin

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Lin more than expected).

Fields of papers citing papers by Xiaolan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Lin. The network helps show where Xiaolan Lin may publish in the future.

Co-authorship network of co-authors of Xiaolan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Lin. A scholar is included among the top collaborators of Xiaolan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Lin. Xiaolan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xiaochun, et al.. (2025). Exosomes derived from baicalin‑pretreated mesenchymal stem cells mitigate atherosclerosis by regulating the SIRT1/NF‑κB signaling pathway. Molecular Medicine Reports. 31(5). 1–13. 3 indexed citations
2.
Lin, Xiaolan, Yunwei Li, Yuping Chen, et al.. (2024). Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma. Frontiers in Immunology. 15. 1337489–1337489. 8 indexed citations
3.
Wang, Ling, Xiaomin Huang, Tian Zheng, et al.. (2024). New light on ω-3 polyunsaturated fatty acids and diabetes debate: a population pharmacokinetic-pharmacodynamic modelling and intake threshold study. Nutrition and Diabetes. 14(1). 8–8. 7 indexed citations
4.
Lin, Xiaolan, Yun Li, Guowei Huang, et al.. (2024). Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma. Frontiers in Immunology. 15. 1337557–1337557. 8 indexed citations
5.
Lin, Xiaolan, et al.. (2024). Algicidal bacteria-derived membrane vesicles as shuttles mediating cross-kingdom interactions between bacteria and algae. Science Advances. 10(32). eadn4526–eadn4526. 4 indexed citations
6.
7.
Pan, Yanbin, et al.. (2023). Prevalence and correlation analysis between post-traumatic stress disorder and analgesic use in survivors of ICU in China. SHILAP Revista de lepidopterología. 73(9). 1811–1815.
8.
Cui, Jingjing, et al.. (2023). Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway. Journal of Ethnopharmacology. 307. 116252–116252. 2 indexed citations
9.
Wang, Liming, Xiaolan Lin, Ling Wang, et al.. (2022). Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations. International Journal of Clinical Pharmacy. 44(6). 1325–1331. 1 indexed citations
10.
Zhuang, Wei, et al.. (2021). Partial response to Chinese patent medicine Kangliu pill for adult glioblastoma: A case report and review of the literature. World Journal of Clinical Cases. 9(12). 2845–2853. 1 indexed citations
11.
Zhuang, Wei, Shaoli Liu, Nan Sun, et al.. (2021). Interaction Between Chinese Medicine and Warfarin: Clinical and Research Update. Frontiers in Pharmacology. 12. 751107–751107. 9 indexed citations
12.
Lin, Xiaolan, Huifang Huang, & Ping Chen. (2020). Retrospective analysis of the clinical features of 172 patients with BCR-ABL1-negative chronic myeloproliferative neoplasms. Molecular Cytogenetics. 13(1). 8–8. 4 indexed citations
13.
Yang, Ying, Li Wu, Ge Sun, et al.. (2020). Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China. Frontiers in Pharmacology. 11. 1066–1066. 69 indexed citations
14.
Zhuang, Wei, Xiaolan Lin, Bin Chen, et al.. (2020). Medication with caution: Analysis of adverse reactions caused by a combination of Chinese medicine and warfarin sodium tablets. Journal of Ethnopharmacology. 254. 112586–112586. 9 indexed citations
15.
Wang, Qinglan, Meimei Liu, Xiaolan Lin, et al.. (2020). Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer. Journal of Cancer. 12(3). 740–753. 16 indexed citations
16.
Lin, Xiaolan, et al.. (2020). Integrated analysis of circRNA-miRNA-mRNA regulatory network identifies potential diagnostic biomarkers in diabetic foot ulcer. Non-coding RNA Research. 5(3). 116–124. 17 indexed citations
17.
Zhuang, Wei, Nan Sun, Liyuan Huang, et al.. (2019). Subacute combined degeneration of the spinal cord is associated with tripterygium glycoside tablet usage. Neurological Sciences. 40(7). 1519–1522. 2 indexed citations
18.
Li, Kang, Jiong Tao, Yuemei Li, et al.. (2018). Patterns of persistence with pharmacological treatment among patients with current depressive episode and their impact on long-term outcome: a naturalistic study with 5-year follow-up. Patient Preference and Adherence. Volume 12. 681–693. 1 indexed citations
19.
Zhuang, Wei, Lifeng Yue, Fei Chen, et al.. (2018). Rosenroot (Rhodiola): Potential Applications in Aging-related Diseases. Aging and Disease. 10(1). 134–134. 66 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashraf Ul Kabir Breakdown of academic impact, for papers by Zhengzhong Wang Breakdown of academic impact, for papers by Lifeng Yue Breakdown of academic impact, for papers by Yajie Cai Breakdown of academic impact, for papers by Hyeon‐Hui Ki Breakdown of academic impact, for papers by Mengting Yu Breakdown of academic impact, for papers by Tianli Pei Breakdown of academic impact, for papers by Chuangpeng Shen
Rankless by CCL
2026